Literature DB >> 6141317

[Blood pressure during isometric and dynamic exercise under long-term antihypertensive treatment with beta receptor blockaders and diuretics].

M Middeke, H Holzgreve.   

Abstract

In 34 men with essential hypertension the increase in blood pressure during static and dynamic exercise, after long-term antihypertensive medication, was investigated in a randomized prospective study. The patients were randomized to either hydrochlorothiazide or to atenolol. The exercise tests were performed after a mean treatment duration of 14 months. At this time, the entering blood pressure was significantly and equally lowered from 163/108 to 148/96 mm Hg with a mean dose of 71 mg hydrochlorothiazide and from 164/108 to 147/91 mm Hg with a mean dose of 144 mg atenolol. The heart rate was significantly lower under beta-blocker therapy (62 min-1) than with diuretics (78 min-1). There were no significant differences in the systolic and diastolic blood pressure rise between the two therapy groups during static exercise with the hand grip (33% of the earlier determined individual maximum for 2 min duration) and with the squatting technique (for 2 min). During dynamic exercise on the bicycle ergometer (50-100 W) the increase in the systolic blood pressure was significantly lower between 70 and 100 W, with a range from 12 to 28 mm Hg, in the beta-blocker group than in the diuretic group. There were no differences in diastolic blood pressure between the two therapy groups. Rate-pressure product as a parameter for the myocardial oxygen consumption and heart rate were significant lower in the beta-blocker group as compared with the diuretic group, at rest and during both kinds of exercise and at all exercise steps.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6141317     DOI: 10.1007/bf01540472

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  21 in total

1.  The vascular effect of the thiazide diuretics.

Authors:  J CONWAY; H PALMERO
Journal:  Arch Intern Med       Date:  1963-02

2.  Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg.

Authors: 
Journal:  JAMA       Date:  1970-08-17       Impact factor: 56.272

3.  Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg.

Authors: 
Journal:  JAMA       Date:  1967-12-11       Impact factor: 56.272

4.  Randomised controlled trial of treatment for mild hypertension: design and pilot trial. Report of Medical Research Council Working Party on Mild to Moderate Hypertension.

Authors: 
Journal:  Br Med J       Date:  1977-06-04

5.  beta-blockers or diuretics in hypertension? A six year follow-up of blood pressure and metabolic side effects.

Authors:  G Berglund; O Andersson
Journal:  Lancet       Date:  1981-04-04       Impact factor: 79.321

6.  Metabolic consequences of atenolol and propranolol in treatment of essential hypertension.

Authors:  J L Day; N Simpson; J Metcalfe; R L Page
Journal:  Br Med J       Date:  1979-01-13

7.  The effect of metoprolol and atenolol on plasma high density lipoprotein levels in man.

Authors:  J D England; L A Simons; J C Gibson; M Carlton
Journal:  Clin Exp Pharmacol Physiol       Date:  1980 May-Jun       Impact factor: 2.557

8.  Differential antihypertensive effect of acebutolol and hydrochlorothiazide/amiloride hydrochloride combination on elevated exercise blood pressures in hypertensive patients.

Authors:  I W Franz
Journal:  Am J Cardiol       Date:  1980-08       Impact factor: 2.778

9.  Effects of antihypertensive therapy on cardiovascular response to exercise.

Authors:  W R Lee; L M Fox; L M Slotkoff
Journal:  Am J Cardiol       Date:  1979-08       Impact factor: 2.778

10.  Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. II. Results of long-term therapy. Veterans Administration Cooperative Study Group on Antihypertensive Agents.

Authors: 
Journal:  JAMA       Date:  1982-10-22       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.